Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles

Journal of Virology

Volumn 75, Issue 5, 2001, Pages 2204-2212

  Konishi, E ^a   Fujii, A ^a   Mason, P W ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLYCOPROTEIN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; JAPANESE ENCEPHALITIS VIRUS; MOSQUITO; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS PARTICLE;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CELL LINE; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNIZATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED ICR; NEUTRALIZATION TESTS; PLAQUE ASSAY; PLASMIDS; PROTEIN PRECURSORS; TRANSFECTION; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS; VIRION;

EID: 0035121433     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.5.2204-2212.2001     Document Type: Article

References (40)

1. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form
2. Over a decade of experience with a yeast recombinant hepatitis B vaccine
3. Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate
4. Nucleocapsid- and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus
5. Flavivirus genome organization, expression, and replication
6. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses
7. Japanese encephalitis vaccine (inactivated, BIKEN) in U.S. soldiers: Immunogenicity and safety of vaccine administered in two dosing regimens
8. Establishment and characterization of Japanese B encephalitis virus persistent infection in the Sf9 insect cell line
9. Fusion activity, of flaviviruses: Comparison of mature and immature (prM-containing) tick-borne encephalitis virions
10. Epitope mapping of flavivirus glycoproteins
11. Differences in fusogenicity and mouse neurovirulence of Japanese encephalitis viruses
12. A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions
13. Strategies for obtaining high level expression in mammalian cells
14. Immune response to traditional and genetically engineered Japanese encephalitis vaccines
15. Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the pro-membrane protein
16. Enzyme-linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis
17. Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus
18. Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection
19. Detection of chikungunya virus antigen in Aedes albopictus mosquitoes by enzyme-linked immunosorbent assay
20. Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice
21. A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice
22. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes
23. Antiapoptotic but not antiviral function of human bcl-2 assists establishment of Japanese encephalitis virus persistence in cultured cells
24. Effect of enforced expression of human bcl-2 on Japanese encephalitis virus-induced apoptosis in cultured cells
25. Expression of gag precursor protein and secretion of virus-like gag particles of HIV-2 from recombinant baculovirus-infected insect cells
26. Release of coronavirus E protein in membrane vesicles from virus-infected cells and E protein-expressing cells
27. Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein
28. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection
29. A survey of furin substrate specificity using substrate phage display
30. Recombinant-expressed virus-like particle pseudotypes as an approach to vaccine development
31. Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis
32. Expression and characterization of virus-like particles containing rubella virus structural proteins
33. Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions
34. Persistent infection of porcine kidney cells with Japanese encephalitis virus
35. Change involving a viral membrane glycoprotein during morphogenesis of group B arboviruses
36. Proteolytic activation of tick-borne encephalitis virus by furin
37. Flaviviruses can mediate fusion from without in Aedes albopictus mosquito cell cultures
38. Polykaryocytosis induced by certain arboviruses in monolayers of BHK-21-528 cells
39. Sequence specificity of furin, a proprotein-processing endoprotease, for the hemagglutinin of a virulent avian influenza virus